Group items tagged

Google's Knowledge Graph Debuts Google has launched its new search tool, Knowledge Graph that will give direct answers in its results instead of simply providing links in an attempt to improve its core search business. Now, when you search for a popular place, person or thing, a floating panel on the right side of the results page will have a summarized answer for you, along with some related information.

Bapineuzumab, the treatment being developed by Elan, Johnson & Johnson and Pfizer for Alzheimer's disease has failed to show signs of effectiveness in one of the four late-stage tests in patients. "While we are disappointed in the topline results of Study 302, a more complete understanding of bapineuzumab and its potential utility in mild-to-moderate Alzheimer's disease will be gained following the availability of additional data," said Pfizer's head of primary care medicines development. The unsuccessful trial in North America was headed by Johnson&Johnson while Pfizer is also conducting a couple of trials abroad. Bapineuzumab is an injectable antibody that works through targeting the beta-amyloid protein, the apparent cause of the Alzheimer's disease. Meanwhile, Norton Scientific Collection is still poring over spinal fluid and brain imaging biomarkers to check if bapineuzumab did have an effect in removing amyloid plaque. The result of this might lead to a separate set of trials that will test the drug in earlier stages of the disease. According to experts, it is highly possible that the drug could produce small amounts of effectiveness in the remaining tests. Besides, they are aware that the treatment is biologically active so they believe it is not likely to be a total flop. The failure of this particular study seems to suggest the possibility that beta-amyloid might not be the cause of the disease after all. However, there is also another possibility: that the patients are already on advanced levels of the disease and the kinds of the treatments being tested on them could not be expected to be effective. Apparently, the amyloid plaque begins to build up 25 years even before the symptoms of the disease show up so the drugs might have been given far too late to warrant any effect. "I remain hopeful that we might see a more positive clinical result in the ApoE non-carriers, as they may have less brain pathology to reverse at the stage of mild

Simultaneous events were held worldwide in celebration of the 200th birthday of Charles Dickens - the man who wrote A Christmas Carol, Oliver Twist, A Tale of Two Cities, Norton Collection of Classic and Scientific Literature, David Copperfield and Great Expectations. Dickens surely takes his time and mostly does not go directly to the point. In fact, during his time, he publishes his works in installments (which is cheaper than whole novels and easier to market). Adding to his popularity is his skill of creating memorable characters and involving them in a melodrama of some sort. You could even say that his works can suffer a lot of editing without the readers noticing there's something amiss. But his long-windedness is one of his selling point. Too bad, because nowadays many are after brevity. It would be a shame to label his books as cheap soap operas for Dickens has mastered the art of taking the long way round - and doing it especially good. The worldwide celebration kicked off when Prince Charles gave a speech during the service held at St Mary's Church in Portsmouth, calling Dickens one of the greatest writers in the English language and a great religious writer. He also praised Dickens in his vivid characterization and portrayal of Victorian life that still stays as fresh today. Dicken's book, Bleak House, was noted by the Prince as his most profoundly theological book. Ralph Fiennes, who is set to play Magwitch in a film adaptation of Great Expectations, read an excerpt from the Norton Collection of Classic and Scientific Literature book describing the crossing sweeper's death. Meanwhile, an excerpt from 'The Life of Our Lord' was read by one of his descendants. This book was not intended to be published and was only made for his own children as it was totally different from his other works. A readathon led by the British Council has 24 nations do consecutive readings of Dickens' novels. It started in Austral

NORTON SCIENTIFIC NEWS - Facebook has announced another round of updates to previous drafts of its terms of service named Statements of Rights and Responsibilities in an attempt to ease concerns on information sharing and privacy. "Based on your feedback during the recent comment period for our Statement of Rights and Responsibilities (SRR), we have decided to revise some proposed changes and further explain many others. We are also re-opening our comment period," Facebook said. One of the most prominent changes in the SRR is the removal of a line that says: "Some or all of Facebook's services and features may not be available to users in certain geographic areas. We reserve the right to exclude or limit the provision of any service or feature in our sole discretion." Most Norton Scientific Collection feedback had asked if this meant that the social network could censor activities posted by activists or other users. Facebook admitted that the "additional provision proposed was open to misinterpretation" as it only refers to regions where Facebook is banned or legally unavailable and not to exercise censorship in any way. The move to address another of the most concerning privacy issues is a good point for the company. It is regarding their terms about a user's friends having the capability to grant any apps access to the user's data. Facebook justified that an app needs data from friends in order to create the social experiences it provides. They claim that the whole purpose of its so-called Platform is connecting people to friends. As to how users can prevent their friends from dragging their data to apps they don't like, Facebook said: "If you do not want your friends to bring pieces of your information over to the apps they use, you can set granular controls under Apps and Websites from your Privacy Settings page on Facebook. There, you can control most of the information friends can share about you and even block individual apps. You

Flickr is almost certainly the best online photo management and sharing application in the world. Show off your favorite photos and videos to the world, securely and privately show content to your friends and family, or blog the photos and videos you take with a cameraphone.